Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Zentalis Pharmaceuticals Inc’s stock clocked out at $2.07, up 2.48% from its previous closing price of $2.02. In other words, the price has increased by $2.48 from its previous closing price. On the day, 0.89 million shares were traded.
Ratios:
To gain a deeper understanding of ZNTL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.29 and its Current Ratio is at 7.29. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On June 20, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $28 to $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 06 ’25 when Bruns Ingmar bought 20,000 shares for $2.28 per share. The transaction valued at 45,656 led to the insider holds 36,629 shares of the business.
Cam Gallagher bought 687 shares of ZNTL for $1,374 on Feb 11 ’25. On Feb 03 ’25, another insider, Vultaggio Vincent, who serves as the PAO and Interim PFO of the company, sold 2,615 shares for $1.71 each. As a result, the insider received 4,476 and left with 189,826 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.64 while its Price-to-Book (P/B) ratio in mrq is 0.42.
Stock Price History:
Over the past 52 weeks, ZNTL has reached a high of $18.07, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is -16.83%, while the 200-Day Moving Average is calculated to be -51.08%.
Shares Statistics:
A total of 71.15M shares are outstanding, with a floating share count of 53.59M. Insiders hold about 24.81% of the company’s shares, while institutions hold 87.48% stake in the company.
